(2) Promote cartilage repair by activating the TGF- /Smad3 signaling pathway
The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro in the UK in 2023, and it is now available on NHS prescription for eligible patients with type 2 diabetes who meet specific criteria outlined by the National Institute for Health and Care Excellence (NICE)
These are uncommon with GHK-Cu but warrant attention if they occur
On efficacy, orforglipron sits between oral semaglutide and injected tirzepatide
Jeon, Took, and Peters have no actual or potential conflicts of interest in relation to this activity
When to Seek Urgent Care: Patients should seek immediate medical attention for severe, persistent abdominal pain (especially if radiating to the back), persistent vomiting leading to dehydration, or right upper quadrant pain with fever or jaundice